Related Experiment Video
Updated: May 2, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Distinct antibiotic treatment regimens differentially affect colonization resistance against multi-drug resistant
Markus M Heimesaat1, Soraya Mousavi1, Nizar W Shayya1
1Gastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Abstract:
Besides its live-saving properties, antibiotic treatment affects the commensal microbiota facilitating colonization with potentially harmful microorganisms. Here we tested how commonly applied antibiotics induced gut microbiota changes and predisposed to intestinal carriage of multi-drug resistant Pseudomonas aeruginosa (MDR Psae) upon exposure. Therefore, mice received either vancomycin, ciprofloxacin, ampicillin plus sulbactam (A/S) or no antibiotics via the drinking water and were perorally challenged with a clinical MDR Psae isolate after antibiotic withdrawal. Whereas 100% of A/S and 55% of ciprofloxacin pretreated mice harbored Psae in their feces seven days post-challenge, intestinal Psae carriage rates were 20.0% and 26.3% in vancomycin pretreated and untreated mice, respectively. Microbiota analyses revealed that immediately before MDR Psae challenge, A/S pretreated mice displayed the lowest total bacterial, lactobacilli and Clostridium leptum fecal loads compared to other cohorts. Seven days following Psae exposure, however, higher numbers of apoptotic colonic epithelial cells were observed in A/S pretreated versus untreated mice that were accompanied by more enhanced innate and adaptive immune cell responses and nitric oxide secretion in colonic and ileal biopsies in the former versus the latter. In conclusion, distinct gut microbiota shifts following A/S pretreatment facilitate pronounced intestinal MDR Psae colonization and pro-inflammatory immune responses upon oral exposure.
Insights
Antibiotic treatment disrupts gut microbiota, increasing susceptibility to harmful bacteria like multi-drug resistant Pseudomonas aeruginosa (MDR Psae). Specific antibiotic combinations like ampicillin plus sulbactam (A/S) significantly enhance Psae colonization and inflammation.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Antibiotics, while life-saving, can disrupt the gut microbiota.
- This disruption may facilitate the colonization of pathogenic microorganisms, including antibiotic-resistant bacteria.
Purpose of the Study:
- To investigate how common antibiotics alter gut microbiota composition.
- To determine if these antibiotic-induced changes predispose to intestinal carriage of multi-drug resistant Pseudomonas aeruginosa (MDR Psae).
Main Methods:
- Mice were treated with vancomycin, ciprofloxacin, ampicillin plus sulbactam (A/S), or no antibiotics.
- Following antibiotic withdrawal, mice were challenged with a clinical MDR Psae isolate.
- Fecal carriage of Psae, gut microbiota composition, and host immune responses were analyzed.
Main Results:
- Ampicillin plus sulbactam (A/S) and ciprofloxacin treatments led to high Psae fecal carriage rates (100% and 55%, respectively).
- Vancomycin and untreated groups showed significantly lower Psae carriage (20.0% and 26.3%).
- A/S pretreatment resulted in reduced beneficial bacteria, increased Psae colonization, heightened immune responses, and elevated nitric oxide secretion.
Conclusions:
- Specific antibiotic regimens, particularly A/S, profoundly alter the gut microbiota.
- These alterations create a favorable environment for MDR Psae colonization.
- Antibiotic-induced dysbiosis can exacerbate intestinal inflammation upon exposure to MDR Psae.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance